AMZEEQ is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Journey Medical Corporation. The primary component is Minocycline Hydrochloride.
| Product ID | 72356-101_0aebe7ba-e714-4400-9197-239b9db39788 |
| NDC | 72356-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AMZEEQ |
| Generic Name | Minocycline |
| Dosage Form | Aerosol, Foam |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2020-01-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212379 |
| Labeler Name | Journey Medical Corporation |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Active Ingredient Strength | 40 mg/g |
| Pharm Classes | Tetracycline-class Drug [EPC], Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-01-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-01-02 |
| Marketing Category | NDA |
| Application Number | NDA212379 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2020-01-02 |
| Ingredient | Strength |
|---|---|
| MINOCYCLINE HYDROCHLORIDE | 40 mg/g |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69489-201 | AMZEEQ | Minocycline |
| 72356-101 | AMZEEQ | Minocycline |
| 42291-589 | Minocycline | Minocycline |
| 42291-591 | Minocycline | Minocycline |
| 49884-511 | Minocycline | Minocycline |
| 49884-512 | Minocycline | Minocycline |
| 49884-513 | Minocycline | Minocycline |
| 63629-2228 | Minocycline | Minocycline |
| 63629-2229 | Minocycline | Minocycline |
| 69489-212 | ZILXI | Minocycline |
| 72356-103 | ZILXI | Minocycline |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AMZEEQ 88246823 not registered Live/Pending |
Foamix Pharmaceuticals Ltd. 2019-01-02 |
![]() AMZEEQ 87554383 not registered Live/Pending |
FOAMIX PHARMACEUTICALS LTD. 2017-08-03 |